-
Something wrong with this record ?
A pilot study of the UVA-photoprotective potential of dehydrosilybin, isosilybin, silychristin, and silydianin on human dermal fibroblasts
A. Rajnochová Svobodová, E. Gabrielová, J. Ulrichová, B. Zálešák, D. Biedermann, J. Vostálová,
Language English Country Germany
Document type Journal Article
Grant support
GACR 15-10897S
Grantová Agentura České Republiky
IGA_LF_2019_015
Univerzita Palackého v Olomouci (CZ)
IGA_LF_2018_012
Univerzita Palackého v Olomouci
RVO 61989592
Univerzita Palackého v Olomouci
- MeSH
- Cytoprotection drug effects MeSH
- Fibroblasts drug effects radiation effects MeSH
- Glutathione metabolism MeSH
- Heme Oxygenase-1 metabolism MeSH
- DNA Breaks, Single-Stranded radiation effects MeSH
- Protein Carbonylation radiation effects MeSH
- Caspase 3 metabolism MeSH
- Cells, Cultured MeSH
- Skin radiation effects MeSH
- Humans MeSH
- Matrix Metalloproteinase 1 metabolism MeSH
- Sunscreening Agents pharmacology MeSH
- HSP70 Heat-Shock Proteins metabolism MeSH
- Reactive Oxygen Species metabolism MeSH
- Silymarin analogs & derivatives pharmacology MeSH
- Ultraviolet Rays adverse effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
The exposure of naked unprotected skin to solar radiation may result in numerous acute and chronic undesirable effects. Evidence suggests that silymarin, a standardized extract from Silybum marianum (L.) Gaertn. seeds, and its major component silybin suppress UVB-induced skin damage. Here, we aimed to investigate the UVA-protective effects of silymarin's less abundant flavonolignans, specifically isosilybin (ISB), silychristin (SC), silydianin (SD), and 2,3-dehydrosilybin (DHSB). Normal human dermal fibroblasts (NHDF) pre-treated for 1 h with flavonolignans were then exposed to UVA light using a solar simulator. Their effects on reactive oxygen species (ROS), carbonylated proteins and glutathione (GSH) level, caspase-3 activity, single-strand breaks' (SSBs) formation and protein level of matrix metalloproteinase-1 (MMP-1), heme oxygenase-1 (HO-1), and heat shock protein (HSP70) were evaluated. The most pronounced preventative potential was found for DHSB, a minor component of silymarin, and SC, the second most abundant flavonolignan in silymarin. They had significant effects on most of the studied parameters. Meanwhile, a photoprotective effect of SC was mostly found at double the concentration of DHSB. ISB and SD protected against GSH depletion, the generation of ROS, carbonylated proteins and SSBs, and caspase-3 activation, but had no significant effect on MMP-1, HO-1, or HSP70. In summary, DHSB and to a lesser extent other silymarin flavonolignans are potent UVA-protective compounds. However, due to the in vitro phototoxic potential of DHSB published elsewhere, further studies are needed to exclude phototoxicity for humans as well as to confirm our results on human skin ex vivo and in vivo.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044834
- 003
- CZ-PrNML
- 005
- 20211221133323.0
- 007
- ta
- 008
- 200109s2019 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00403-019-01928-7 $2 doi
- 035 __
- $a (PubMed)31079190
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Rajnochová Svobodová, Alena $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15, Olomouc, Czech Republic.
- 245 12
- $a A pilot study of the UVA-photoprotective potential of dehydrosilybin, isosilybin, silychristin, and silydianin on human dermal fibroblasts / $c A. Rajnochová Svobodová, E. Gabrielová, J. Ulrichová, B. Zálešák, D. Biedermann, J. Vostálová,
- 520 9_
- $a The exposure of naked unprotected skin to solar radiation may result in numerous acute and chronic undesirable effects. Evidence suggests that silymarin, a standardized extract from Silybum marianum (L.) Gaertn. seeds, and its major component silybin suppress UVB-induced skin damage. Here, we aimed to investigate the UVA-protective effects of silymarin's less abundant flavonolignans, specifically isosilybin (ISB), silychristin (SC), silydianin (SD), and 2,3-dehydrosilybin (DHSB). Normal human dermal fibroblasts (NHDF) pre-treated for 1 h with flavonolignans were then exposed to UVA light using a solar simulator. Their effects on reactive oxygen species (ROS), carbonylated proteins and glutathione (GSH) level, caspase-3 activity, single-strand breaks' (SSBs) formation and protein level of matrix metalloproteinase-1 (MMP-1), heme oxygenase-1 (HO-1), and heat shock protein (HSP70) were evaluated. The most pronounced preventative potential was found for DHSB, a minor component of silymarin, and SC, the second most abundant flavonolignan in silymarin. They had significant effects on most of the studied parameters. Meanwhile, a photoprotective effect of SC was mostly found at double the concentration of DHSB. ISB and SD protected against GSH depletion, the generation of ROS, carbonylated proteins and SSBs, and caspase-3 activation, but had no significant effect on MMP-1, HO-1, or HSP70. In summary, DHSB and to a lesser extent other silymarin flavonolignans are potent UVA-protective compounds. However, due to the in vitro phototoxic potential of DHSB published elsewhere, further studies are needed to exclude phototoxicity for humans as well as to confirm our results on human skin ex vivo and in vivo.
- 650 _2
- $a kaspasa 3 $x metabolismus $7 D053148
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a cytoprotekce $x účinky léků $7 D019610
- 650 _2
- $a jednořetězcové zlomy DNA $x účinky záření $7 D053904
- 650 _2
- $a fibroblasty $x účinky léků $x účinky záření $7 D005347
- 650 _2
- $a glutathion $x metabolismus $7 D005978
- 650 _2
- $a proteiny tepelného šoku HSP70 $x metabolismus $7 D018840
- 650 _2
- $a hemoxygenasa-1 $x metabolismus $7 D051547
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a matrixová metaloproteinasa 1 $x metabolismus $7 D020781
- 650 _2
- $a karbonylace proteinů $x účinky záření $7 D050050
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 650 _2
- $a silymarin $x analogy a deriváty $x farmakologie $7 D012838
- 650 _2
- $a kůže $x účinky záření $7 D012867
- 650 _2
- $a přípravky chránící proti slunci $x farmakologie $7 D013473
- 650 _2
- $a ultrafialové záření $x škodlivé účinky $7 D014466
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gabrielová, Eva $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15, Olomouc, Czech Republic. $7 xx0267682
- 700 1_
- $a Ulrichová, Jitka $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15, Olomouc, Czech Republic.
- 700 1_
- $a Zálešák, Bohumil $u Department of Plastic and Aesthetic Surgery, University Hospital Olomouc, I. P. Pavlova 6, 779 00, Olomouc, Czech Republic.
- 700 1_
- $a Biedermann, David $u Laboratory of Biotransformation, Institute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20, Prague, Czech Republic.
- 700 1_
- $a Vostálová, Jitka $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15, Olomouc, Czech Republic. jitka.vostalova@upol.cz.
- 773 0_
- $w MED00009242 $t Archives of dermatological research $x 1432-069X $g Roč. 311, č. 6 (2019), s. 477-490
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31079190 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20211221133318 $b ABA008
- 999 __
- $a ok $b bmc $g 1483103 $s 1083507
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 311 $c 6 $d 477-490 $e 20190511 $i 1432-069X $m Archives of dermatological research $n Arch Dermatol Res $x MED00009242
- GRA __
- $a GACR 15-10897S $p Grantová Agentura České Republiky
- GRA __
- $a IGA_LF_2019_015 $p Univerzita Palackého v Olomouci (CZ)
- GRA __
- $a IGA_LF_2018_012 $p Univerzita Palackého v Olomouci
- GRA __
- $a RVO 61989592 $p Univerzita Palackého v Olomouci
- LZP __
- $a Pubmed-20200109